obesity treatment with bariatric surgery vs glp-1 receptor agonists Interest in for the Management of Insufficient Weight Loss or Weight Regain After | Surgery Glucagon‐Like Peptide‐1 Receptor Agonists Versus
Description
By Primary Use FDA-approved indications are product-specific and based on clinical trial data for each formulation and dose
Mulvihill, E
10.1016/S2213-8587(19)30249-9 45 LamC
One of the key challenges was that the receptor has 463 amino acids
[DOI] [PubMed] [Google Scholar] 35.Kadouh H, Chedid V, Halawi H, et al
95% CI 6.21, 2.29), GLP-1 RAs/SGLT2is (WMD: 3.2%
